Clinical trialNCT05757102RecruitingPhase 3Interventional

A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma

SponsorGlaxoSmithKlineEnrollment292Asthma

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The primary purpose of this study is to evaluate the effects of Fluticasone Furoate (FF)/ Umeclidinium (UMEC)/ Vilanterol (VI) on lung function compared with FF/VI after 24 weeks of treatment.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

GSK Clinical Trials
GlaxoSmithKline
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

62 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Argentina

Gsk Investigational Site
Buenos Aires, Argentina
Horacio Budani
Recruiting
Gsk Investigational Site
Buenos Aires, Argentina
Abel Esteban Bordon
Recruiting
Gsk Investigational Site
Buenos Aires, Argentina
Monica Silvia De Gennaro
Recruiting
Gsk Investigational Site
Buenos Aires, Argentina
Anahi Yanez
Recruiting
Gsk Investigational Site
Buenos Aires, Argentina
Andrea Medina
Recruiting
Gsk Investigational Site
Córdoba, Argentina
Victor Hugo Cambursano
Recruiting
Gsk Investigational Site
Lanus, Argentina
Adriana Sosso
Recruiting
Gsk Investigational Site
Lobos, Argentina
Fabian Dabove
Recruiting
Gsk Investigational Site
Lujan de Cuyo, Argentina
Cristian Fazio
Recruiting
Gsk Investigational Site
Mar del Plata, Argentina
Jorge Taborda
Recruiting
Gsk Investigational Site
Rosario, Argentina
Adriana Marcipar
Recruiting
Gsk Investigational Site
Rosario Provincia de Santa FE, Argentina
Gabriel Gattolin
Recruiting
Gsk Investigational Site
San Miguel de Tucumán, Argentina
Ramona Silvia del Valle Orosco Segura
Recruiting
Gsk Investigational Site
Santa Fe, Argentina
Martin Edgardo Roberto Maillo
Recruiting

Australia

Gsk Investigational Site
South Brisbane, Queensland, Australia
Ajay Kevat
Recruiting
Gsk Investigational Site
North Adelaide, South Australia, Australia
Andrew Tai
Recruiting
Gsk Investigational Site
Joondalup WA, Western Australia, Australia
Desiree Silva
Recruiting

Chile

Gsk Investigational Site
Lo Barnechea, Chile
Alberto Vidal Grell
Recruiting
Gsk Investigational Site
Santiago, Chile
Maria Palomino
Recruiting
Gsk Investigational Site
Santiago, Chile
Daniela Valenzuela Venandy
Recruiting

Israel

Gsk Investigational Site
Ashkelon, Israel
Alina Avenshtein
Recruiting
Gsk Investigational Site
Haifa, Israel
Michal Gur
Recruiting
Gsk Investigational Site
Haifa, Israel
Karin Yaacoby-Bianu
Recruiting
Gsk Investigational Site
Petah Tikva, Israel
Meir Mei-Zahav
Recruiting

Mexico

Gsk Investigational Site
Guadalajara, Mexico
Daniel Alejandro Salazar-Quiroz
Recruiting
Gsk Investigational Site
Monterrey, Mexico
Sandra Gonzalez-Diaz
Recruiting
Gsk Investigational Site
San Juan del Río, Mexico
Mario Rosas-Navarro
Recruiting

New Zealand

Gsk Investigational Site
Ebdentown, Upper Hutt, New Zealand
Tim Humphrey
Recruiting

South Korea

Gsk Investigational Site
Cheongju Chungcheongbuk-do, South Korea
Youn-Soo Hahn
Recruiting
Gsk Investigational Site
Seoul, South Korea
Completed
Gsk Investigational Site
Seoul, South Korea
Jinho Yu
Recruiting
Gsk Investigational Site
Seoul, South Korea
Ju Kim
Recruiting

Turkey (Türkiye)

Gsk Investigational Site
Adana, Turkey (Türkiye)
Dilek Ozcan
Recruiting
Gsk Investigational Site
Antalya, Turkey (Türkiye)
Aysen Bingol
Recruiting
Gsk Investigational Site
Istanbul, Turkey (Türkiye)
Cansin Sackesen
Recruiting
Gsk Investigational Site
Istanbul, Turkey (Türkiye)
Ahmet Ozen
Recruiting

United States

Gsk Investigational Site
Birmingham, Alabama, United States
Weily Soong
Recruiting
Gsk Investigational Site
Mobile, Alabama, United States
Lawrence Sindel
Recruiting
Gsk Investigational Site
Paradise Valley, Arizona, United States
Michael Manning
Recruiting
Gsk Investigational Site
Bakersfield, California, United States
Eric Boren
Recruiting

22 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

FF/UMEC/VIFF/VI

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 25 Apr 2023
Primary completion: 22 Jan 2027
Completion: 28 Jan 2027
Last update posted: 16 Jul 2026
Registered enrollment: 292
Registry id: NCT05757102

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.